Empire Co. Ltd A Stock

Upon examining the financial statements of Empire Company Limited (EMLAF) in the Food & Drug Retailing industry, it is evident that the company has shown steady growth in recent years. However, a comprehensive analysis of the data provided will provide a clearer picture of its current state and potential for future growth.

Increasing Revenue and Gross Profit: Over the past three years, both revenue and gross profit have increased consistently. In FY2020, the total revenue stood at CAD 26.59 billion, which grew to CAD 28.27 billion in FY2021 and CAD 30.16 billion in FY2022. Similarly, the gross profit has increased from CAD 6.63 billion in FY2020 to CAD 7.20 billion in FY2021 and CAD 7.66 billion in FY2022. This consistent growth trend in both revenue and gross profit is a positive sign for the company's overall financial health.

Consistent Net Income Growth: EMLAF's net income has also increased consistently over the last three years. In FY2020, the net income was CAD 583.5 million, which grew to CAD 701.5 million in FY2021 and CAD 745.8 million in FY2022. This consistent growth in net income showcases the company's ability to manage its expenses effectively and generate higher profits.